How PwC Turns ‘Corporate Antibodies’ Into Allies

Every company has antibodies, or necessary guardians of the enterprise. Mitra Best of PwC shares five tactics that can help productively engage these antibodies.

By Patricia Riedman Yeager · June 8, 2016 · 1 min read

As most readers of InnoLead are painfully aware, the death of good ideas at the hands of business units — sometimes referred to as “organ rejection” — is a common problem. In fact, according to our 2015 Innovation Benchmarking Report , published last year with innovation…

More like this

Addressing the Corporate Antibodies That Attack Open Innovation

Three Tactics to Spur Innovation Inside Highly-Regulated Companies

These Are the Things That Kill Innovation Initiatives

COMMENTS